Business Context and Reporting Period
Company: ProKidney Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: January 12, 2026
Reporting Period: Single event date (January 12, 2026)
Business Context: The Company is an emerging growth company incorporated in Delaware, with principal executive offices in Winston-Salem, North Carolina. Its Class A common stock trades on The Nasdaq Stock Market under the symbol "PROK".
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document serves solely to disclose the update of an investor presentation.
Material Changes
Item 7.01 Regulation FD Disclosure: The Company has updated its investor presentation, which senior management intends to use when interacting with investors and analysts. The updated presentation is available on the Company's website and is attached as Exhibit 99.1.
Guidance, Outlook, and Risks
Management Commentary: The filing explicitly states that the information provided in Item 7.01 and Exhibit 99.1 is being furnished, not filed, pursuant to Regulation FD. Consequently, this information will not be incorporated by reference into any registration statement unless specifically identified.
Disclaimers: The Company states that the furnishing of this information is not intended to, and does not, constitute a determination or admission that the information is material or complete. Investors are advised that they should not consider this information before making an investment decision.
Key Facts for Investor Verification
- Verify the content of the updated investor presentation (Exhibit 99.1) directly on the Company's investor relations website.
- Confirm that the information in the presentation is not incorporated by reference into other SEC filings.
- Note that this 8-K filing contains no audited financial data or specific operational metrics for the period.
- Review the Company's status as an emerging growth company for potential differences in financial reporting standards.